Bloomberg: Bayer in exclusive talks for Merck consumer health business

Bayer (BAYZF, BAYRY) is in exclusive talks to buy Merck's (MRK) consumer health business for ~$14B, and a deal announcement is likely in the next few days, Bloomberg reports.

Reckitt Benckiser said yesterday it was no longer in active discussions for the business.

A deal would strengthen MRK’s core drug business while aiding Bayer's consumer products line by adding brands including Claritin.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs